Cystobactamide derivatives

US11034648B2 · kind B2 · utility

Assignees

• HELMHOLTZ-ZENTRUM FÜR · DE
• INFEKTIONSFORSCHUNG GMBH · DE

Inventors

• Giambattista Testolin · Braunschweig, DE
• Mark Brönstrup · Frankfurt, DE
• Hans-Peter Prochnow · Braunschweig, DE
• Jennifer Herrmann · Braunschweig, DE
• Rolf Muller · Karben, DE
• Charlotte Grandclaudon · Braunschweig, DE
• Tim Mollner · Braunschweig, DE
• Antje Ritter · Braunschweig, DE

Key dates

• Filing date: Aug 23, 2018
• Grant date: Jun 15, 2021
• Expiry date: Aug 23, 2038

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to novel derivatives of cystobactamides of formula (Ib) and the use thereof for the treatment or prophylaxis of bacterial infections.